← FDA Drug Approvals (Drugs@FDA)

MOUNJARO

NDA · New Drug Application · Sponsor: ELI LILLY AND CO · Approved 2022-05-13

Drug application

FDA Application #

NDA215866

Application type

New Drug Application

Brand name

MOUNJARO

Generic name

TIRZEPATIDE

Active ingredients

TIRZEPATIDE

Dosage form

SOLUTION

Route

SUBCUTANEOUS

Marketing status

Prescription

Sponsor

ELI LILLY AND CO

Manufacturer

Eli Lilly and Company

First approval

2022-05-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown